AllPennyStocks.com Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Other Penny Stock Movers

Casino Tables Are Going Social, and This Microcap Just Expanded Its Reach
Curaleaf Eyes Aurora Cannabis in Deal That Could Reshape the Global Cannabis Market
Scandium Explorer Jumps 15% on Shift from Metallurgical Sampling to Extension Drilling
Most Popular
{{ index + 1 }}


Back to Top